Baldwin Wealth Partners LLC MA Reduces Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Baldwin Wealth Partners LLC MA trimmed its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 64.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,362 shares of the company's stock after selling 6,143 shares during the quarter. Baldwin Wealth Partners LLC MA's holdings in Ryan Specialty were worth $216,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Hollencrest Capital Management acquired a new stake in shares of Ryan Specialty during the 3rd quarter worth about $25,000. Assetmark Inc. purchased a new stake in shares of Ryan Specialty in the 3rd quarter valued at approximately $34,000. Quarry LP raised its stake in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after acquiring an additional 422 shares during the period. GAMMA Investing LLC boosted its position in shares of Ryan Specialty by 106.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock worth $83,000 after purchasing an additional 644 shares during the period. Finally, Signaturefd LLC increased its holdings in Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after purchasing an additional 148 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on RYAN. Morgan Stanley initiated coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an "overweight" rating and a $90.00 price target for the company. Bank of America raised their target price on Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating on the stock in a research note on Friday, January 10th. Barclays raised their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group upped their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Ryan Specialty has a consensus rating of "Hold" and an average price target of $74.40.

Ryan Specialty Stock Up 0.1 %

Shares of Ryan Specialty stock traded up $0.08 during trading on Friday, hitting $66.69. 959,457 shares of the stock were exchanged, compared to its average volume of 1,027,323. The stock has a market cap of $17.46 billion, a price-to-earnings ratio of 86.61, a price-to-earnings-growth ratio of 1.15 and a beta of 0.72. The firm's 50-day moving average price is $66.93 and its 200 day moving average price is $66.40. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 12-month low of $42.21 and a 12-month high of $75.97.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. The business had revenue of $604.69 million during the quarter, compared to analysts' expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business's quarterly revenue was up 20.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 EPS. As a group, analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current fiscal year.

Insider Activity

In other news, Director David P. Bolger sold 7,055 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the transaction, the director now owns 78,149 shares in the company, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the business's stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the sale, the director now directly owns 45,409 shares in the company, valued at approximately $2,954,309.54. This represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 306,887 shares of company stock worth $20,402,023. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.